NPI: 1144471715 · SPOKANE, WA 99204 · Psychiatric Hospital Unit · NPI assigned 10/01/2008
Authorized official ANDERSON, DONALD controls 20+ related entities in our dataset. Read more
| Authorized Official | ANDERSON, DONALD (ASSISTANT SECRETARY FOR ENROLLMENT) |
| NPI Enumeration Date | 10/01/2008 |
Other providers sharing the same authorized official: ANDERSON, DONALD
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 407,738 | $11.43M |
| 2019 | 402,219 | $11.25M |
| 2020 | 356,389 | $9.82M |
| 2021 | 397,711 | $11.40M |
| 2022 | 375,226 | $11.86M |
| 2023 | 362,218 | $11.64M |
| 2024 | 305,158 | $11.42M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 81,085 | 75,055 | $10.73M |
| 96361 | Intravenous infusion, hydration; each additional hour | 29,513 | 26,406 | $9.33M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 62,205 | 57,989 | $5.84M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 54,547 | 50,444 | $4.32M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 37,564 | 25,772 | $3.77M |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 13,145 | 12,890 | $3.35M |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 19,236 | 15,090 | $2.10M |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 4,526 | 4,459 | $1.90M |
| 70450 | Computed tomography, head or brain; without contrast material | 12,807 | 12,159 | $1.88M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 23,475 | 21,739 | $1.86M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 10,177 | 9,872 | $1.68M |
| S9480 | Intensive outpatient psychiatric services, per diem | 3,393 | 600 | $1.58M |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 6,745 | 5,050 | $1.56M |
| 44970 | 450 | 449 | $1.54M | |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | 4,095 | 4,040 | $1.53M |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 10,272 | 9,897 | $1.38M |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 6,668 | 6,217 | $982K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 9,597 | 9,234 | $928K |
| 54161 | 530 | 527 | $699K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 4,300 | 4,148 | $695K |
| 67311 | 339 | 334 | $669K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 2,347 | 2,188 | $655K |
| H2012 | Behavioral health day treatment, per hour | 1,882 | 276 | $652K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 1,391 | 1,372 | $646K |
| 93304 | 1,564 | 1,533 | $622K | |
| 93458 | 671 | 648 | $588K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 6,092 | 5,748 | $585K |
| 93308 | 2,003 | 1,944 | $584K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 1,630 | 1,591 | $574K |
| 93325 | 9,113 | 8,798 | $548K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 2,740 | 2,672 | $543K |
| 80053 | Comprehensive metabolic panel | 105,893 | 89,208 | $542K |
| 43235 | 1,404 | 1,372 | $504K | |
| C8929 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography | 2,356 | 2,304 | $485K |
| 95819 | 2,182 | 2,162 | $473K | |
| G0378 | Hospital observation service, per hour | 25,892 | 11,995 | $470K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 3,219 | 3,124 | $465K |
| 87631 | 9,149 | 8,707 | $456K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 15,473 | 14,220 | $447K |
| 12011 | 1,761 | 1,740 | $396K | |
| 12001 | 1,698 | 1,682 | $363K | |
| 58571 | 148 | 145 | $362K | |
| 96415 | 1,280 | 965 | $337K | |
| 95816 | 1,278 | 1,260 | $293K | |
| 36430 | 1,700 | 1,176 | $289K | |
| 93017 | 2,707 | 2,650 | $277K | |
| 76770 | 2,253 | 2,213 | $266K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 3,106 | 1,971 | $259K |
| 93971 | 2,355 | 2,252 | $198K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 472 | 460 | $186K |
| 80048 | Basic metabolic panel (calcium, ionized) | 36,255 | 30,373 | $164K |
| 70498 | 1,510 | 1,482 | $160K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 14,996 | 14,627 | $158K |
| J1561 | Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | 96 | 77 | $142K |
| 12002 | 768 | 757 | $137K | |
| 95700 | 741 | 727 | $137K | |
| 36415 | Collection of venous blood by venipuncture | 72,723 | 59,455 | $131K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 122,466 | 102,184 | $128K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 2,975 | 2,892 | $128K |
| 96367 | 2,695 | 2,344 | $127K | |
| 70496 | 1,566 | 1,528 | $117K | |
| 76830 | Ultrasound, transvaginal | 1,516 | 1,479 | $115K |
| 93975 | 1,880 | 1,829 | $111K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 1,935 | 1,887 | $111K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 13,890 | 10,066 | $108K |
| 84484 | 25,999 | 18,306 | $105K | |
| 78264 | 284 | 280 | $105K | |
| 84443 | Thyroid stimulating hormone (TSH) | 18,049 | 17,495 | $101K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 3,335 | 3,241 | $97K |
| 83880 | 11,453 | 9,998 | $97K | |
| 96450 | 232 | 196 | $93K | |
| 43244 | 186 | 182 | $91K | |
| 87040 | 12,250 | 7,226 | $85K | |
| 20680 | 67 | 63 | $83K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 26,505 | 25,211 | $78K |
| 90870 | 420 | 171 | $77K | |
| 74230 | 915 | 886 | $77K | |
| 77072 | 1,554 | 1,547 | $75K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 12,732 | 12,131 | $72K |
| 95714 | 213 | 176 | $69K | |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 57 | 48 | $69K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 5,063 | 4,944 | $68K |
| 71046 | Radiologic examination, chest; 2 views | 21,513 | 20,568 | $67K |
| 76937 | 1,306 | 1,222 | $67K | |
| 70491 | 338 | 326 | $64K | |
| 83735 | 29,403 | 21,320 | $63K | |
| 93321 | 3,988 | 3,878 | $59K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 8,324 | 8,146 | $59K |
| 76870 | 617 | 589 | $59K | |
| 83605 | 12,764 | 10,130 | $58K | |
| 70486 | 1,608 | 1,558 | $58K | |
| 47562 | 24 | 24 | $53K | |
| 88307 | 2,605 | 2,484 | $53K | |
| J3490 | Unclassified drugs | 4,346 | 3,873 | $52K |
| 83970 | 2,646 | 2,418 | $51K | |
| 88142 | 3,766 | 3,752 | $51K | |
| 82784 | 6,307 | 5,329 | $50K | |
| 76801 | 772 | 734 | $49K | |
| 86140 | 20,660 | 18,631 | $47K | |
| 74240 | 461 | 456 | $46K | |
| G0249 | Provision of test materials and equipment for home inr monitoring of patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; includes: provision of materials for use in the home and reporting of test results to physician; testing not occurring more frequently than once a week; testing materials, billing units of service include 4 tests | 1,951 | 1,746 | $46K |
| 84145 | 5,505 | 5,046 | $45K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 2,941 | 2,920 | $45K |
| 90715 | 2,650 | 2,599 | $44K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 41,390 | 37,465 | $44K |
| 97161 | 1,290 | 1,245 | $43K | |
| 80050 | General health panel | 6,540 | 6,426 | $43K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 988 | 961 | $42K |
| 93320 | 4,121 | 4,059 | $42K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 4,241 | 4,084 | $42K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 2,421 | 1,276 | $40K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 3,853 | 3,586 | $40K |
| 29125 | 223 | 217 | $39K | |
| 97162 | 1,375 | 1,306 | $39K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 39,106 | 35,817 | $37K |
| 87641 | 3,176 | 3,110 | $36K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 3,639 | 3,592 | $36K |
| 87186 | 12,353 | 11,943 | $36K | |
| 74018 | 6,495 | 6,133 | $36K | |
| 49083 | 74 | 36 | $36K | |
| 80069 | 6,227 | 4,532 | $36K | |
| 85027 | 26,916 | 21,891 | $34K | |
| 87486 | 3,363 | 3,266 | $34K | |
| 87581 | 3,362 | 3,265 | $34K | |
| 87077 | 10,116 | 9,763 | $34K | |
| 97166 | 1,222 | 1,156 | $33K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 34,404 | 28,512 | $33K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 4,286 | 4,190 | $31K |
| 80061 | Lipid panel | 5,260 | 5,174 | $30K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 2,027 | 1,979 | $29K |
| 43237 | 123 | 120 | $29K | |
| 96409 | 2,108 | 1,132 | $28K | |
| 94729 | 778 | 761 | $28K | |
| 82570 | 7,780 | 7,020 | $28K | |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | 14 | 14 | $28K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1,739 | 1,703 | $27K |
| 85379 | 5,575 | 5,330 | $27K | |
| 10060 | 147 | 142 | $26K | |
| 36561 | 27 | 27 | $25K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 172 | 168 | $25K |
| 84439 | 6,090 | 5,919 | $25K | |
| 71045 | Radiologic examination, chest; single view | 19,728 | 18,167 | $24K |
| 85652 | 12,325 | 11,604 | $22K | |
| J9312 | Injection, rituximab, 10 mg | 17 | 12 | $22K |
| 81001 | 55,454 | 50,924 | $22K | |
| 85610 | 34,205 | 23,977 | $21K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 5,062 | 4,945 | $21K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 55 | 55 | $20K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 183 | 182 | $20K |
| 80143 | 4,947 | 4,687 | $20K | |
| 82728 | 5,487 | 5,209 | $20K | |
| 87505 | 261 | 251 | $19K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 5,548 | 5,434 | $19K |
| 10061 | 93 | 93 | $19K | |
| 76882 | 217 | 202 | $18K | |
| 88342 | 3,651 | 3,533 | $18K | |
| 97165 | 576 | 545 | $18K | |
| 76825 | 249 | 231 | $18K | |
| 59025 | Fetal non-stress test | 100 | 96 | $17K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 658 | 629 | $17K |
| 84305 | 1,298 | 1,287 | $17K | |
| 85007 | 4,653 | 3,557 | $17K | |
| 80306 | 15,832 | 14,881 | $16K | |
| 84156 | 6,448 | 5,649 | $16K | |
| 84146 | 1,199 | 1,174 | $16K | |
| 83550 | 3,671 | 3,532 | $16K | |
| P9040 | Red blood cells, leukocytes reduced, irradiated, each unit | 58 | 52 | $16K |
| 86803 | 2,705 | 2,668 | $15K | |
| 87088 | 6,683 | 6,415 | $15K | |
| P9047 | Infusion, albumin (human), 25%, 50 ml | 75 | 38 | $15K |
| 87081 | 3,441 | 3,394 | $15K | |
| 86780 | 1,497 | 1,469 | $15K | |
| 29848 | 14 | 13 | $15K | |
| 86850 | 9,863 | 8,838 | $15K | |
| 83516 | 2,445 | 2,080 | $15K | |
| 82533 | 1,324 | 1,102 | $15K | |
| 84100 | 10,162 | 6,878 | $14K | |
| 80197 | 2,317 | 1,379 | $14K | |
| 93531 | 12 | 12 | $14K | |
| 87070 | 7,268 | 6,742 | $14K | |
| 86923 | 1,277 | 1,064 | $14K | |
| 80164 | 1,961 | 1,732 | $13K | |
| 31624 | 40 | 38 | $13K | |
| 86364 | 1,978 | 1,961 | $13K | |
| 94060 | 345 | 334 | $12K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 12,501 | 9,480 | $12K |
| 43259 | 44 | 44 | $12K | |
| 82962 | 45,174 | 25,150 | $12K | |
| 84403 | 1,101 | 1,073 | $12K | |
| 87205 | 8,230 | 7,578 | $12K | |
| 80076 | 2,444 | 2,270 | $11K | |
| 83690 | 26,005 | 24,023 | $11K | |
| G0379 | Direct admission of patient for hospital observation care | 524 | 514 | $11K |
| 95812 | 29 | 29 | $11K | |
| 87075 | 4,937 | 4,589 | $11K | |
| 84702 | 7,042 | 6,518 | $11K | |
| 29105 | 92 | 92 | $10K | |
| 87340 | 3,283 | 3,213 | $10K | |
| 83540 | 4,077 | 3,916 | $10K | |
| 86900 | 9,978 | 8,820 | $10K | |
| 80179 | 4,688 | 4,476 | $10K | |
| 92960 | 42 | 38 | $10K | |
| 88185 | 288 | 154 | $10K | |
| 83001 | 1,083 | 1,051 | $9K | |
| 86901 | 10,539 | 9,345 | $9K | |
| 43752 | 21 | 13 | $9K | |
| 83002 | 1,019 | 983 | $9K | |
| 82607 | 1,580 | 1,558 | $9K | |
| 70487 | 74 | 73 | $9K | |
| 36573 | 15 | 13 | $9K | |
| 71250 | 225 | 218 | $9K | |
| 81025 | 21,976 | 20,929 | $9K | |
| 94660 | 63 | 37 | $9K | |
| 83874 | 1,958 | 1,891 | $9K | |
| 76827 | 263 | 242 | $8K | |
| 94726 | 268 | 260 | $8K | |
| 85014 | 5,178 | 4,449 | $8K | |
| 82105 | 810 | 775 | $8K | |
| 86480 | 548 | 538 | $8K | |
| 51600 | 24 | 24 | $7K | |
| 74019 | 2,860 | 2,765 | $7K | |
| 82670 | 563 | 552 | $7K | |
| P9016 | Red blood cells, leukocytes reduced, each unit | 56 | 50 | $7K |
| 95951 | 37 | 26 | $7K | |
| 92611 | 742 | 718 | $7K | |
| 82043 | 3,334 | 3,228 | $7K | |
| 82785 | 685 | 656 | $6K | |
| 86160 | 1,063 | 1,010 | $6K | |
| 82550 | 4,158 | 3,406 | $6K | |
| 25605 | 13 | 13 | $6K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 1,406 | 1,387 | $6K |
| 83520 | 1,113 | 968 | $6K | |
| 49452 | 12 | 12 | $6K | |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 16 | 12 | $6K |
| 43242 | 14 | 14 | $5K | |
| 90686 | 648 | 638 | $5K | |
| 82565 | 2,285 | 2,091 | $5K | |
| 85576 | 550 | 442 | $5K | |
| 74174 | 38 | 38 | $5K | |
| 72141 | 38 | 38 | $5K | |
| 80178 | 670 | 597 | $5K | |
| 82077 | 12,685 | 11,777 | $5K | |
| 86762 | 1,281 | 1,270 | $5K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 4,187 | 4,019 | $5K |
| 88304 | 2,283 | 2,255 | $5K | |
| 85730 | 7,665 | 6,938 | $5K | |
| 73130 | 2,508 | 2,354 | $5K | |
| 84436 | 457 | 450 | $5K | |
| 96376 | 14,102 | 10,571 | $5K | |
| 94770 | 78 | 53 | $5K | |
| 73562 | 1,473 | 1,434 | $5K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 55,970 | 45,203 | $5K |
| 88313 | 903 | 841 | $4K | |
| J2704 | Injection, propofol, 10 mg | 34,911 | 31,622 | $4K |
| 86376 | 359 | 355 | $4K | |
| 84112 | 616 | 571 | $4K | |
| 82248 | 1,947 | 1,585 | $4K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 332 | 329 | $4K |
| 97535 | Self-care/home management training, each 15 minutes | 373 | 253 | $4K |
| 99152 | 3,451 | 3,248 | $4K | |
| 88341 | 1,051 | 993 | $4K | |
| 87147 | 2,071 | 2,025 | $4K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 33,442 | 26,978 | $4K |
| 43762 | 39 | 36 | $4K | |
| 86592 | 1,078 | 1,069 | $4K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 20,034 | 18,696 | $4K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 33 | 33 | $4K |
| 43247 | 12 | 12 | $4K | |
| 85018 | 4,167 | 3,459 | $4K | |
| 72100 | 1,752 | 1,645 | $4K | |
| 84550 | 2,118 | 1,960 | $4K | |
| 86704 | 1,190 | 1,168 | $4K | |
| 86361 | 282 | 276 | $4K | |
| 72040 | 1,194 | 1,096 | $4K | |
| 87511 | 399 | 396 | $4K | |
| C1874 | Stent, coated/covered, with delivery system | 43 | 40 | $4K |
| 85049 | 1,286 | 1,271 | $3K | |
| 99153 | Mod sedat endo service >5yrs | 3,269 | 3,105 | $3K |
| 86706 | 1,055 | 1,028 | $3K | |
| 10120 | 12 | 12 | $3K | |
| 93880 | 74 | 74 | $3K | |
| 73630 | 2,352 | 2,201 | $3K | |
| 74328 | 126 | 121 | $3K | |
| 86038 | 885 | 867 | $3K | |
| 87799 | 399 | 271 | $3K | |
| 86003 | 413 | 346 | $3K | |
| 73610 | 2,592 | 2,348 | $3K | |
| 82805 | 757 | 661 | $3K | |
| 84460 | 1,359 | 1,212 | $3K | |
| 88184 | 581 | 527 | $3K | |
| 73030 | 2,287 | 2,069 | $3K | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 25,157 | 21,791 | $3K |
| 82746 | 744 | 734 | $3K | |
| 92585 | 13 | 13 | $3K | |
| 81003 | 10,412 | 9,360 | $3K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 21,804 | 19,472 | $3K |
| J1170 | Injection, hydromorphone, up to 4 mg | 25,645 | 18,230 | $3K |
| 84703 | 7,372 | 7,096 | $3K | |
| 85046 | 2,709 | 2,072 | $3K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 26,557 | 24,867 | $2K |
| 89230 | 91 | 89 | $2K | |
| 83615 | 2,450 | 1,881 | $2K | |
| 95957 | 34 | 24 | $2K | |
| 82247 | 525 | 395 | $2K | |
| 73090 | 2,076 | 1,725 | $2K | |
| 82950 | 707 | 706 | $2K | |
| 86800 | 138 | 137 | $2K | |
| 87184 | 1,033 | 1,005 | $2K | |
| C8930 | Transthoracic echocardiography, with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report; including performance of continuous electrocardiographic monitoring, with physician supervision | 50 | 49 | $2K |
| 82610 | 260 | 253 | $2K | |
| 82977 | 852 | 684 | $2K | |
| 87497 | 179 | 128 | $2K | |
| 93312 | 13 | 13 | $2K | |
| M0247 | Intravenous infusion, sotrovimab, includes infusion and post administration monitoring | 16 | 16 | $2K |
| 73502 | 1,389 | 1,268 | $2K | |
| 82803 | 4,227 | 3,821 | $2K | |
| 74455 | 12 | 12 | $2K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 27,164 | 23,065 | $2K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 23,404 | 21,852 | $2K |
| 73700 | 42 | 38 | $2K | |
| 87899 | 1,188 | 615 | $2K | |
| J1815 | Injection, insulin, per 5 units | 10,124 | 4,014 | $2K |
| 87481 | 418 | 365 | $2K | |
| 87046 | 632 | 614 | $2K | |
| 87210 | 2,192 | 2,115 | $2K | |
| J7030 | Infusion, normal saline solution , 1000 cc | 24,024 | 20,657 | $2K |
| 73110 | 1,586 | 1,464 | $2K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 220 | 146 | $2K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 2,781 | 2,690 | $2K |
| 73552 | 765 | 688 | $2K | |
| 82150 | 1,085 | 948 | $2K | |
| 73590 | 1,999 | 1,757 | $2K | |
| A9541 | Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries | 648 | 640 | $2K |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 8,351 | 3,876 | $2K |
| 87209 | 202 | 200 | $2K | |
| 87493 | 399 | 384 | $2K | |
| 73560 | 1,170 | 1,098 | $2K | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 2,713 | 2,370 | $2K |
| 89051 | 1,801 | 1,500 | $2K | |
| 82626 | 107 | 103 | $1K | |
| 82947 | 1,995 | 1,810 | $1K | |
| 83519 | 167 | 162 | $1K | |
| Q0247 | Injection, sotrovimab, 500 mg | 16 | 16 | $1K |
| J0690 | Injection, cefazolin sodium, 500 mg | 15,083 | 11,552 | $1K |
| 82140 | 836 | 753 | $1K | |
| 73140 | 697 | 675 | $1K | |
| 87522 | Neg quan hep c or qual rna | 75 | 75 | $1K |
| 84295 | 1,731 | 1,593 | $1K | |
| 86231 | 253 | 252 | $1K | |
| 81015 | 396 | 387 | $1K | |
| J7050 | Infusion, normal saline solution, 250 cc | 30,204 | 18,348 | $1K |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 7,000 | 6,675 | $1K |
| 99157 | 89 | 86 | $1K | |
| 87116 | 178 | 148 | $1K | |
| 96368 | 240 | 134 | $1K | |
| 87045 | 617 | 605 | $1K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 8,336 | 6,286 | $1K |
| 88112 | 240 | 221 | $1K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 10,796 | 8,546 | $1K |
| 97802 | 27 | 27 | $1K | |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 892 | 867 | $1K |
| 73080 | 949 | 889 | $993.48 | |
| 86360 | 70 | 68 | $964.69 | |
| C1769 | Guide wire | 6,798 | 6,369 | $956.74 |
| 82951 | 117 | 117 | $948.05 | |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 2,267 | 2,205 | $932.31 |
| J9370 | Vincristine sulfate, 1 mg | 1,271 | 885 | $917.77 |
| 93970 | 13 | 12 | $883.35 | |
| Q9957 | Injection, perflutren lipid microspheres, per ml | 3,249 | 3,166 | $862.45 |
| 87177 | 201 | 199 | $855.76 | |
| 72126 | 233 | 223 | $852.95 | |
| A9585 | Injection, gadobutrol, 0.1 ml | 3,220 | 3,148 | $796.79 |
| 87634 | 828 | 808 | $779.96 | |
| 85384 | 1,299 | 1,163 | $753.23 | |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 4,108 | 3,841 | $752.39 |
| 99155 | 46 | 45 | $739.73 | |
| 82024 | 41 | 40 | $715.73 | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 1,740 | 1,617 | $699.27 |
| 82330 | 529 | 440 | $686.74 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1,248 | 622 | $658.23 |
| 96417 | 15 | 12 | $642.00 | |
| 80175 | 98 | 88 | $639.55 | |
| 81002 | 2,297 | 1,911 | $637.41 | |
| 84450 | 394 | 369 | $625.87 | |
| C1889 | Implantable/insertable device, not otherwise classified | 579 | 544 | $614.89 |
| 86147 | 53 | 40 | $604.47 | |
| C2617 | Stent, non-coronary, temporary, without delivery system | 238 | 227 | $571.87 |
| 87338 | 106 | 106 | $570.25 | |
| 84402 | 105 | 104 | $567.32 | |
| 87176 | 337 | 317 | $563.38 | |
| 86200 | 121 | 120 | $562.42 | |
| 88275 | 18 | 12 | $562.07 | |
| 0399T | 121 | 119 | $558.29 | |
| 85670 | 429 | 349 | $557.56 | |
| 84132 | 2,459 | 2,136 | $549.09 | |
| 84478 | 281 | 172 | $541.02 | |
| 86225 | 184 | 174 | $534.12 | |
| 84480 | 94 | 94 | $528.68 | |
| 89060 | 233 | 221 | $526.65 | |
| 86708 | 199 | 195 | $525.46 | |
| 82438 | 67 | 65 | $514.34 | |
| J1756 | Injection, iron sucrose, 1 mg | 65 | 39 | $497.23 |
| J3370 | Injection, vancomycin hcl, 500 mg | 5,857 | 3,673 | $492.45 |
| D0220 | Intraoral - periapical first radiographic image | 70 | 68 | $489.14 |
| 99156 | 13 | 13 | $470.72 | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 5,663 | 4,604 | $466.40 |
| D1206 | Topical application of fluoride varnish | 93 | 90 | $457.78 |
| 82310 | 173 | 146 | $454.74 | |
| 85240 | 92 | 82 | $453.54 | |
| 36591 | 105 | 90 | $450.62 | |
| 86317 | 72 | 41 | $440.73 | |
| J1644 | Injection, heparin sodium, per 1000 units | 10,109 | 5,404 | $432.13 |
| 82627 | 62 | 62 | $428.04 | |
| 82553 | 57 | 55 | $423.72 | |
| 84445 | 15 | 15 | $419.48 | |
| 86431 | 142 | 129 | $412.66 | |
| 88271 | 12 | 12 | $399.80 | |
| A9270 | Non-covered item or service | 34,314 | 5,630 | $394.42 |
| 94668 | 19 | 12 | $390.72 | |
| 87206 | 619 | 406 | $381.32 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 8,231 | 7,025 | $372.87 |
| 86039 | 62 | 62 | $363.79 | |
| C1751 | Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) | 1,218 | 1,125 | $354.85 |
| 94010 | 14 | 14 | $345.65 | |
| 82010 | 680 | 587 | $342.20 | |
| 72170 | 339 | 327 | $341.25 | |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | 1,616 | 1,092 | $340.28 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 719 | 578 | $336.79 |
| 94727 | 15 | 14 | $335.19 | |
| 73070 | 461 | 389 | $330.57 | |
| 86235 | 45 | 36 | $328.41 | |
| 73564 | 124 | 118 | $325.73 | |
| J2310 | Injection, naloxone hydrochloride, per 1 mg | 41 | 27 | $321.89 |
| 83655 | 26 | 26 | $312.78 | |
| 84446 | 28 | 28 | $302.91 | |
| 88237 | 12 | 12 | $292.94 | |
| D0150 | Comprehensive oral evaluation - new or established patient | 69 | 67 | $279.68 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 3,846 | 3,512 | $276.02 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 2,238 | 2,180 | $268.10 |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | 2,657 | 2,323 | $264.71 |
| J0280 | Injection, aminophyllin, up to 250 mg | 730 | 712 | $262.91 |
| 83993 | 30 | 30 | $236.45 | |
| J9045 | Injection, carboplatin, 50 mg | 16 | 13 | $236.13 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 23,027 | 17,958 | $233.97 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 7,176 | 2,982 | $233.15 |
| 90670 | 12 | 12 | $224.33 | |
| D0230 | Intraoral - periapical each additional radiographic image | 59 | 56 | $217.17 |
| 80177 | 42 | 38 | $215.29 | |
| 84520 | 976 | 911 | $200.08 | |
| 80074 | 39 | 38 | $194.93 | |
| 87015 | 230 | 192 | $184.54 | |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | 975 | 880 | $180.87 |
| 84481 | 16 | 16 | $177.66 | |
| 84144 | 25 | 25 | $175.17 | |
| 73060 | 211 | 196 | $174.36 | |
| 83010 | 13 | 12 | $172.01 | |
| 88311 | 137 | 120 | $170.05 | |
| 88264 | 12 | 12 | $166.80 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 3,174 | 2,572 | $165.37 |
| 84466 | 41 | 41 | $153.22 | |
| 80202 | 16 | 12 | $141.30 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 4,682 | 3,237 | $140.28 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 1,673 | 1,502 | $138.72 |
| 89055 | 45 | 43 | $131.15 | |
| 90656 | 17 | 17 | $124.34 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 3,093 | 2,640 | $118.61 |
| 87806 | 1,391 | 1,373 | $111.63 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 218 | 215 | $111.32 |
| 51798 | 25 | 25 | $109.37 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | 2,952 | 2,367 | $104.36 |
| 84590 | 13 | 13 | $103.08 | |
| 70250 | 12 | 12 | $98.01 | |
| C9113 | Injection, pantoprazole sodium, per vial | 2,938 | 1,873 | $95.63 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 9,899 | 8,967 | $91.25 |
| 86334 | 13 | 13 | $77.53 | |
| 73000 | 58 | 54 | $70.98 | |
| J1245 | Injection, dipyridamole, per 10 mg | 775 | 749 | $67.58 |
| 84165 | 14 | 14 | $66.24 | |
| 82435 | 794 | 756 | $65.92 | |
| 88300 | 62 | 62 | $63.19 | |
| 86258 | 15 | 15 | $62.86 | |
| 72072 | 63 | 63 | $61.02 | |
| J9260 | Injection, methotrexate sodium, 50 mg | 419 | 292 | $58.06 |
| 86015 | 12 | 12 | $52.80 | |
| 87807 | 107 | 107 | $51.97 | |
| 84075 | 14 | 13 | $50.93 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 272 | 175 | $49.26 |
| J2060 | Injection, lorazepam, 2 mg | 6,268 | 5,162 | $47.68 |
| 86665 | 25 | 13 | $43.87 | |
| J0295 | Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm | 3,861 | 1,723 | $43.78 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 281 | 280 | $43.09 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 17 | 17 | $41.03 |
| 87430 | 29 | 29 | $39.60 | |
| 86037 | 13 | 12 | $38.56 | |
| 88108 | 49 | 48 | $38.27 | |
| J1940 | Injection, furosemide, up to 20 mg | 1,669 | 1,212 | $37.33 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 973 | 802 | $37.23 |
| 87102 | 52 | 43 | $36.89 | |
| J0694 | Injection, cefoxitin sodium, 1 gm | 146 | 86 | $36.80 |
| 36416 | 308 | 293 | $36.00 | |
| J1953 | Injection, levetiracetam, 10 mg | 419 | 340 | $35.42 |
| 86308 | 67 | 66 | $34.48 | |
| 87181 | 13 | 13 | $26.68 | |
| 81050 | 15 | 15 | $26.46 | |
| Q0177 | Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 2,635 | 1,977 | $25.97 |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 52 | 52 | $25.80 |
| J8540 | Dexamethasone, oral, 0.25 mg | 1,945 | 1,669 | $25.04 |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 1,043 | 404 | $25.00 |
| 76010 | 36 | 36 | $23.34 | |
| 88312 | 13 | 13 | $20.77 | |
| 86664 | 13 | 13 | $19.53 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 3,378 | 2,133 | $18.93 |
| J1630 | Injection, haloperidol, up to 5 mg | 881 | 745 | $16.44 |
| J3480 | Injection, potassium chloride, per 2 meq | 2,142 | 1,441 | $13.02 |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 15 | 12 | $13.02 |
| 85246 | 13 | 12 | $11.96 | |
| J3411 | Injection, thiamine hcl, 100 mg | 1,804 | 1,232 | $11.75 |
| 84157 | 28 | 28 | $8.26 | |
| 82945 | 38 | 38 | $8.10 | |
| J0500 | Injection, dicyclomine hcl, up to 20 mg | 391 | 317 | $3.44 |
| C1725 | Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) | 1,044 | 861 | $3.28 |
| C1766 | Introducer/sheath, guiding, intracardiac electrophysiological, steerable, other than peel-away | 229 | 215 | $3.25 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 766 | 706 | $2.91 |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | 23 | 13 | $2.20 |
| J0744 | Injection, ciprofloxacin for intravenous infusion, 200 mg | 87 | 65 | $1.87 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 1,257 | 1,206 | $1.00 |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 25 | 24 | $0.90 |
| Q0244 | Injection, casirivimab and imdevimab, 1200 mg | 13 | 13 | $0.03 |
| J1920 | Injection, labetalol hydrochloride, 5 mg | 190 | 160 | $0.00 |
| G8987 | Self care functional limitation, current status, at therapy episode outset and at reporting intervals | 238 | 223 | $0.00 |
| J1790 | Injection, droperidol, up to 5 mg | 915 | 856 | $0.00 |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 1,722 | 1,655 | $0.00 |
| C1726 | Catheter, balloon dilatation, non-vascular | 151 | 146 | $0.00 |
| S2900 | Surgical techniques requiring use of robotic surgical system (list separately in addition to code for primary procedure) | 99 | 96 | $0.00 |
| 73600 | 14 | 13 | $0.00 | |
| J2470 | Injection, pantoprazole sodium, 40 mg | 88 | 66 | $0.00 |
| J1836 | Injection, metronidazole, 10 mg | 353 | 253 | $0.00 |
| S9981 | Medical records copying fee, administrative | 17 | 16 | $0.00 |
| J0456 | Injection, azithromycin, 500 mg | 74 | 58 | $0.00 |
| J2305 | Injection, nitroglycerin, 5 mg | 129 | 113 | $0.00 |
| J7999 | Compounded drug, not otherwise classified | 166 | 135 | $0.00 |
| 96411 | 39 | 25 | $0.00 | |
| G8988 | Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 216 | 203 | $0.00 |
| 43264 | 12 | 12 | $0.00 | |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 106 | 86 | $0.00 |
| J2785 | Injection, regadenoson, 0.1 mg | 15 | 15 | $0.00 |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 13 | 13 | $0.00 |
| S9982 | Medical records copying fee, per page | 28 | 27 | $0.00 |
| 72020 | 61 | 44 | $0.00 | |
| J1805 | Injection, esmolol hydrochloride, 10 mg | 12 | 12 | $0.00 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 218 | 180 | $0.00 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 367 | 342 | $0.00 |
| 0100U | 33 | 32 | $0.00 | |
| J2359 | Injection, olanzapine, 0.5 mg | 123 | 106 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 310 | 295 | $0.00 |
| J0134 | Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg | 457 | 425 | $0.00 |
| 93356 | 671 | 655 | $0.00 | |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 329 | 308 | $0.00 |
| J0692 | Injection, cefepime hydrochloride, 500 mg | 264 | 121 | $0.00 |
| S0080 | Injection, pentamidine isethionate, 300 mg | 157 | 140 | $0.00 |
| J3415 | Injection, pyridoxine hcl, 100 mg | 208 | 176 | $0.00 |
| J0688 | Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg | 568 | 490 | $0.00 |
| 71100 | 12 | 12 | $0.00 | |
| G8989 | Self care functional limitation, discharge status, at discharge from therapy or to end reporting | 28 | 27 | $0.00 |
| J2004 | Injection, lidocaine hcl with epinephrine, 1 mg | 101 | 100 | $0.00 |
| C1758 | Catheter, ureteral | 12 | 12 | $0.00 |
| J1956 | Injection, levofloxacin, 250 mg | 55 | 42 | $0.00 |
| J2720 | Injection, protamine sulfate, per 10 mg | 24 | 24 | $0.00 |
| J0137 | Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg | 13 | 12 | $0.00 |
| G2215 | Take-home supply of nasal naloxone; 2-pack of 4mg per 0.1 ml nasal spray (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure | 16 | 16 | $0.00 |
| J3371 | Injection, vancomycin hcl (mylan), not therapeutically equivalent to j3370, 500 mg | 38 | 24 | $0.00 |
| C1760 | Closure device, vascular (implantable/insertable) | 12 | 12 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 299 | 228 | $0.00 |
| Q9958 | High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml | 13 | 13 | $0.00 |
| J0736 | Injection, clindamycin phosphate, 300 mg | 16 | 12 | $0.00 |
| 51702 | 16 | 15 | $0.00 | |
| C2625 | Stent, non-coronary, temporary, with delivery system | 13 | 13 | $0.00 |
| C1776 | Joint device (implantable) | 14 | 12 | $0.00 |